In April 2023, a new preventative treatment option became available on NHS England for adults living with chronic migraine, following approval from the National Institute for Health and Care Excellence (NICE) in March1.
This is a companion discussion topic for the original article at https://patient.info/news-and-features/vyepti-a-new-drug-for-preventing-migraines